Pralsetinib For Ret Fusion-Positive Non-Small-Cell Lung Cancer (Arrow): A Multi-Cohort, Open-Label, Phase 1/2 Study (Vol 22, Pg 959, 2021)
Justin F. Gainor,Giuseppe Curigliano,Dong-Wan Kim,Dae Ho Lee,Benjamin Besse,Christina S. Baik,Robert C. Doebele,Philippe A. Cassier,Gilberto Lopes,Daniel S. W. Tan,Elena Garralda,Luis G. Paz-Ares,Byoung Chul Cho,Shirish M. Gadgeel,Michael Thomas,Stephen V. Liu,Matthew H. Taylor,Aaron S. Mansfield,Viola W. Zhu,Corinne Clifford,Hui Zhang,Michael Palmer,Jennifer Green,Christopher D. Turner,Vivek Subbiah LANCET ONCOLOGY(2021)
AI 理解论文
溯源树
样例